Pheniramine Maleate 25 mg Tab,Palbociclib 100 mg Tab,Ondansetron 2mg or ml 4 ml Inj,Pantoprazole 40
Dg Armed Forces Medical Service
KANNUR, KERALA
Bid Publish Date
23-Jul-2025, 1:51 pm
Bid End Date
13-Aug-2025, 2:00 pm
EMD
₹1,593
Location
Progress
RAQuantity
32315
Category
Paclitaxel 100mg Inj
Bid Type
Two Packet Bid
A tender has been published for Indian Army Paclitaxel 100mg Inj, Carboplatin 450mg Inj, Docetaxel 80mg slace 2ml vial 6 ml solvent for Inj, 5 Fluorouracil 500mg, 10 ml Inj, Pegylated Liposomal Doxorubicin 20mg Inj, Inj Fosaprepitant 150 mg, Pheniramine Maleate Inj 22 point 75 mg per ml amp of 2 ml, Actinomycin D 0 point 5 mg Inj, Topotecan 2 point 5 mg Inj, Inj Irinotecan 100mg, Etoposide 100mg, 5 ml Inj, Cyclophosphamide 500 mg Inj, Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna, Cisplatin 50mg Inj, Pemetrexed 500mg powder for injection, Inj Pemetrexed 100 mg, inj Bendamustine 100 mg, Bleomycin Sulphate slace Chloride 15mg Inj, Inj Pegylated GCSF 6mg, Vincristine Sulphate 1mg Inj, Gemcitabine 1000mg Inj, Gemcitabine 200mg Inj, Mesna 200mg Inj, Inj Methotrexate 500mg point, inj TPGS Docetaxel 20 mg, inj TPGS Docetaxel 80 mg, inj TPGS Docetaxel 120 mg, Palonosetron 0 point 25 mg slace ml Inj, Tab Netupitant 300 mg plus Palonosetron 0 point 5 mg, Oxaliplatin 100mg Inj, Inj Eribulin, vial of 1 mg, Doxorubicin HCl Inj 2mg slace ml, 25 ml Inj, Epirubicin 50 mg Inj vial of 50 mg, Albumin bound Paclitaxel 100 mg, Erlotinib 150 mg Tab, Gefitinib 250mg Tab, Procarbazine HCl 50 mg Cap, Non coring chemoport needle 20 G slace 22 G, Pack of one needle, Prefilled 0 point 9 percent Sodium Chloride Flush, Aprepitant 1 Cap 125 mg and 2 Cap 80 mg, Tab Dacomitinib 30 mg Bottle of 30 Tab, Tab Cabozantinib 60 mg, cabozantinib 40 gm, Inj avelumab 200 mg slace 10ml, Inj Brentuximab Vedotin 50 mg, Inj Pegylated Liposomal Irinotecan 4 point 3mg slace ml, Inj Bevacizumab 300 mg, Vinblastine Sulphate 10 mg Inj, Vinorelbine 50 mg Inj, Carboplatin 150 mg Inj, Docetaxel 20mg 0 point 5ml vial plus 1 point 5 ml Solvent for Inj, Degarelix 80 mg Inj, Degarelix 120 mg Inj, Oxaliplatin 50mg Inj, Cabazitaxel 60 mg inj, Cytosine Arabinoside 500mg Inj, Cytosine Arabinoside Preservative free 100 mg Inj, Temozolamide 100mg Cap, Pazopanib 200mg tab, Lenvatinib 4 mg tab, Inj Ramucirumab vial of 500mg, Tegafur 15 mg Gimeracil 4 point 3 mg ND Oteracil 11 point 8 mg cap, Tegafur 20 mg Gimeracil 5 point 8 mg ND Oteracil 15 point 8 mg cap, Polatuzumab Vedotin 30 mg Inj, Tab Megestrol acetate 160 mg in KOLKATA, WEST BENGAL. Quantity: 32315 by. Submission Deadline: 13-08-2025 14: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Dg Armed Forces Medical Service
KANNUR, KERALA
Indian Army
HYDERABAD, TELANGANA
Indian Army
DODA, JAMMU & KASHMIR
Indian Army
LEH, JAMMU & KASHMIR
Indian Army
RAJAURI, JAMMU & KASHMIR
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Paclitaxel 100mg Inj | Paclitaxel 100mg Inj | 900 | vial | consignee2dglp | 30 |
| 2 | Carboplatin 450mg Inj | Carboplatin 450mg Inj | 1,200 | amp slace vial | consignee2dglp | 30 |
| 3 | Docetaxel 80mg slace 2ml vial 6 ml solvent for Inj | Docetaxel 80mg/2ml vial 6 ml solvent for Inj | 180 | amp slace vial | consignee2dglp | 30 |
| 4 | 5 Fluorouracil 500mg, 10 ml Inj | 5 Fluorouracil 500mg, 10 ml Inj | 1,800 | amp slace vial | consignee2dglp | 30 |
| 5 | Pegylated Liposomal Doxorubicin 20mg Inj | Pegylated Liposomal Doxorubicin 20mg Inj | 60 | vial | consignee2dglp | 30 |
| 6 | Inj Fosaprepitant 150 mg | Inj Fosaprepitant 150 mg | 150 | vial | consignee2dglp | 30 |
| 7 | Pheniramine Maleate Inj 22 point 75 mg per ml amp of 2 ml | Pheniramine Maleate Inj 22.75 mg per ml amp of 2 ml. | 600 | amp slace vial | consignee2dglp | 30 |
| 8 | Actinomycin D 0 point 5 mg Inj | Actinomycin D 0.5 mg Inj | 30 | amp slace vial | consignee2dglp | 30 |
| 9 | Topotecan 2 point 5 mg Inj | Topotecan 2.5 mg Inj | 60 | amp slace vial | consignee2dglp | 30 |
| 10 | Inj Irinotecan 100mg | Inj Irinotecan 100mg | 68 | vial | consignee2dglp | 30 |
| 11 | Etoposide 100mg, 5 ml Inj | Etoposide 100mg, 5 ml Inj | 150 | amp slace vial | consignee2dglp | 30 |
| 12 | Cyclophosphamide 500 mg Inj | Cyclophosphamide 500 mg Inj | 450 | amp slace vial | consignee2dglp | 30 |
| 13 | Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna | Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna | 300 | amp slace vial | consignee2dglp | 30 |
| 14 | Cisplatin 50mg Inj | Cisplatin 50mg Inj | 600 | amp slace vial | consignee2dglp | 30 |
| 15 | Pemetrexed 500mg powder for injection | Pemetrexed 500mg powder for injection | 75 | vial | consignee2dglp | 30 |
| 16 | Inj Pemetrexed 100 mg | Inj Pemetrexed 100 mg | 60 | vial | consignee2dglp | 30 |
| 17 | inj Bendamustine 100 mg | inj Bendamustine 100 mg | 30 | vial | consignee2dglp | 30 |
| 18 | Bleomycin Sulphate slace Chloride 15mg Inj | Bleomycin Sulphate/Chloride 15mg Inj | 60 | amp slace vial | consignee2dglp | 30 |
| 19 | Inj Pegylated GCSF 6mg | Inj Pegylated GCSF 6mg | 600 | pfs slace pfp slace vial | consignee2dglp | 30 |
| 20 | Vincristine Sulphate 1mg Inj | Vincristine Sulphate 1mg Inj | 150 | amp slace vial | consignee2dglp | 30 |
| 21 | Gemcitabine 1000mg Inj | Gemcitabine 1000mg Inj | 225 | vial | consignee2dglp | 30 |
| 22 | Gemcitabine 200mg Inj | Gemcitabine 200mg Inj | 300 | vial | consignee2dglp | 30 |
| 23 | Mesna 200mg Inj | Mesna 200mg Inj | 2,100 | amp slace vial | consignee2dglp | 30 |
| 24 | Inj Methotrexate 500mg point | Inj Methotrexate 500mg. | 30 | vial | consignee2dglp | 30 |
| 25 | inj TPGS Docetaxel 20 mg | inj TPGS Docetaxel 20 mg | 600 | no | consignee2dglp | 30 |
| 26 | inj TPGS Docetaxel 80 mg | inj TPGS Docetaxel 80 mg | 60 | no | consignee2dglp | 30 |
| 27 | inj TPGS Docetaxel 120 mg | inj TPGS Docetaxel 120 mg | 60 | no | consignee2dglp | 30 |
| 28 | Palonosetron 0 point 25 mg slace ml Inj | Palonosetron 0.25 mg/ml Inj | 2,700 | amp | consignee2dglp | 30 |
| 29 | Tab Netupitant 300 mg plus Palonosetron 0 point 5 mg | Tab Netupitant 300 mg + Palonosetron 0.5 mg | 300 | nos | consignee2dglp | 30 |
| 30 | Oxaliplatin 100mg Inj | Oxaliplatin 100mg Inj | 300 | vial | consignee2dglp | 30 |
| 31 | Inj Eribulin, vial of 1 mg | Inj Eribulin, vial of 1 mg | 45 | vial | consignee2dglp | 30 |
| 32 | Doxorubicin HCl Inj 2mg slace ml, 25 ml Inj | Doxorubicin HCl Inj 2mg/ml, 25 ml Inj | 50 | amp slace vial | consignee2dglp | 30 |
| 33 | Epirubicin 50 mg Inj vial of 50 mg | Epirubicin 50 mg Inj vial of 50 mg | 30 | vial | consignee2dglp | 30 |
| 34 | Albumin bound Paclitaxel 100 mg | Albumin bound Paclitaxel 100 mg | 300 | vial | consignee2dglp | 30 |
| 35 | Erlotinib 150 mg Tab | Erlotinib 150 mg Tab | 1,050 | no | consignee2dglp | 30 |
| 36 | Gefitinib 250mg Tab | Gefitinib 250mg Tab | 900 | no | consignee2dglp | 30 |
| 37 | Procarbazine HCl 50 mg Cap | Procarbazine HCl 50 mg Cap | 200 | no | consignee2dglp | 30 |
| 38 | Non coring chemoport needle 20 G slace 22 G, Pack of one needle | Non coring chemoport needle 20 G/22 G, Pack of one needle | 360 | pack | consignee2dglp | 30 |
| 39 | Prefilled 0 point 9 percent Sodium Chloride Flush | Prefilled (0.9% Sodium Chloride ) Flush | 600 | pfs | consignee2dglp | 30 |
| 40 | Aprepitant 1 Cap 125 mg and 2 Cap 80 mg | Aprepitant 1 Cap 125 mg & 2 Cap 80 mg | 900 | no | consignee2dglp | 30 |
| 41 | Albumin bound Paclitaxel 100 mg | Albumin bound Paclitaxel 100 mg | 150 | vial | consignee2dglp | 30 |
| 42 | Tab Dacomitinib 30 mg Bottle of 30 Tab | Tab Dacomitinib 30 mg (Bottle of 30 Tab) | 12 | bottle | consignee2dglp | 30 |
| 43 | Tab Cabozantinib 60 mg | Tab Cabozantinib 60 mg | 720 | nos | consignee2dglp | 30 |
| 44 | cabozantinib 40 gm | cabozantinib 40 gm | 1,440 | nos | consignee2dglp | 30 |
| 45 | Inj avelumab 200 mg slace 10ml | Inj avelumab 200 mg /10ml | 60 | vial | consignee2dglp | 30 |
| 46 | Inj Brentuximab Vedotin 50 mg | Inj Brentuximab Vedotin 50 mg | 18 | vial | consignee2dglp | 30 |
| 47 | Inj Pegylated Liposomal Irinotecan 4 point 3mg slace ml | Inj Pegylated Liposomal Irinotecan 4.3mg/ml | 180 | vial of 10 ml | consignee2dglp | 30 |
| 48 | Inj Bevacizumab 300 mg | Inj Bevacizumab 300 mg | 300 | vial | consignee2dglp | 30 |
| 49 | Vinblastine Sulphate 10 mg Inj | Vinblastine Sulphate 10 mg Inj | 30 | vial | consignee2dglp | 30 |
| 50 | Vinorelbine 50 mg Inj | Vinorelbine 50 mg Inj | 210 | vial | consignee2dglp | 30 |
| 51 | Carboplatin 150 mg Inj | Carboplatin 150 mg Inj | 200 | vial | consignee2dglp | 30 |
| 52 | Docetaxel 20mg 0 point 5ml vial plus 1 point 5 ml Solvent for Inj | Docetaxel 20mg 0.5ml vial + 1.5 ml Solvent for Inj | 180 | vial | consignee2dglp | 30 |
| 53 | Degarelix 80 mg Inj | Degarelix 80 mg Inj | 12 | vial | consignee2dglp | 30 |
| 54 | Degarelix 120 mg Inj | Degarelix 120 mg Inj | 6 | vial | consignee2dglp | 30 |
| 55 | Oxaliplatin 50mg Inj | Oxaliplatin 50mg Inj | 300 | amp slace vial | consignee2dglp | 30 |
| 56 | Cabazitaxel 60 mg inj | Cabazitaxel 60 mg inj | 15 | vials | consignee2dglp | 30 |
| 57 | Cytosine Arabinoside 500mg Inj | Cytosine Arabinoside 500mg Inj | 75 | amp slace vial | consignee2dglp | 30 |
| 58 | Cytosine Arabinoside Preservative free 100 mg Inj | Cytosine Arabinoside (Preservative free) 100 mg Inj | 150 | amp slace vial | consignee2dglp | 30 |
| 59 | Temozolamide 100mg Cap | Temozolamide 100mg Cap | 3,600 | no | consignee2dglp | 30 |
| 60 | Pazopanib 200mg tab | Pazopanib 200mg tab | 1,200 | no | consignee2dglp | 30 |
| 61 | Lenvatinib 4 mg tab | Lenvatinib 4 mg tab | 600 | no | consignee2dglp | 30 |
| 62 | Inj Ramucirumab vial of 500mg | Inj Ramucirumab vial of 500mg | 12 | vial | consignee2dglp | 30 |
| 63 | Tegafur 15 mg Gimeracil 4 point 3 mg ND Oteracil 11 point 8 mg cap | Tegafur 15 mg Gimeracil 4.3 mg ND Oteracil 11.8 mg cap | 300 | no | consignee2dglp | 30 |
| 64 | Tegafur 20 mg Gimeracil 5 point 8 mg ND Oteracil 15 point 8 mg cap | Tegafur 20 mg Gimeracil 5.8 mg ND Oteracil 15.8 mg cap | 300 | no | consignee2dglp | 30 |
| 65 | Polatuzumab Vedotin 30 mg Inj | Polatuzumab Vedotin 30 mg Inj | 12 | vial | consignee2dglp | 30 |
| 66 | Tab Megestrol acetate 160 mg | Tab Megestrol acetate 160 mg | 3,600 | nos | consignee2dglp | 30 |
Start
26-Sep-2025, 3:00 pm
End
27-Sep-2025, 5:47 pm
Duration: 27 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 13-08-2025 12:56:15 | Evaluated |
| 2 | ********** Under PMA | - | 12-08-2025 19:43:53 | Evaluated |
| 3 | ********** Under PMA | - | 06-08-2025 12:09:01 | Evaluated |
| 4 | ********** Under PMA | - | 13-08-2025 13:34:04 | Evaluated |
| 5 | ********** Under PMA | - | 12-08-2025 18:38:28 | Evaluated |
| 6 | ********** Under PMA | - | 13-08-2025 11:46:12 | Evaluated |
| 7 | ********** Under PMA | - | 12-08-2025 16:28:26 | Evaluated |
| 8 | ********** Under PMA | - | 12-08-2025 18:12:53 | Evaluated |
| 9 | ********** Under PMA | - | 11-08-2025 20:03:41 | Evaluated |
| 10 | ********** Under PMA | - | 13-08-2025 12:39:30 | Evaluated |
| 11 | ********** Under PMA | - | 13-08-2025 12:45:21 | Evaluated |
| 12 | ********** Under PMA | - | 04-08-2025 18:20:36 | Evaluated |
| 13 | ********** Under PMA | - | 13-08-2025 12:28:47 | Evaluated |
| 14 | ********** Under PMA | - | 11-08-2025 18:16:56 | Evaluated |
| 15 | ********** Under PMA | - | 12-08-2025 20:27:20 | Evaluated |
| 16 | ********** Under PMA | - | 08-08-2025 18:45:00 | Evaluated |
| 17 | ********** Under PMA | - | 13-08-2025 13:12:37 | Evaluated |
| 18 | ********** Under PMA | - | 12-08-2025 13:56:58 | Evaluated |
| 19 | ********** Under PMA | - | 12-08-2025 17:58:06 | Evaluated |
| 20 | ********** Under PMA | - | 08-08-2025 16:45:20 | Evaluated |
| 21 | ********** Under PMA | - | 12-08-2025 17:14:00 | Evaluated |
| 22 | ********** Under PMA | - | 13-08-2025 12:04:58 | Evaluated |
| 23 | ********** Under PMA | - | 13-08-2025 13:28:07 | Evaluated |
| 24 | ********** Under PMA | - | 08-08-2025 12:08:19 | Evaluated |
| 25 | ********** Under PMA | - | 13-08-2025 13:46:04 | Evaluated |
| 26 | ********** Under PMA | - | 12-08-2025 22:33:30 | Evaluated |
| 27 | ********** Under PMA | - | 13-08-2025 11:16:13 | Evaluated |
| 28 | ********** Under PMA | - | 13-08-2025 13:31:48 | Evaluated |
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS